Bayer, Monsanto Move Closer to Sealing Deal

The video discusses the ongoing negotiations between Buyer and Monsanto, highlighting the narrowing gap in their offer and the optimism for a resolution. It addresses antitrust concerns, with Buyer considering selling its dermatology business to ease regulatory hurdles. The video also explores potential strategies for addressing market share issues in seeds and pesticides, emphasizing the importance of regulatory compliance to finalize the deal.

What is the current offer price per share from Bayer to Monsanto?

• $125.00

• $130.00

• $135.00

• $127.50

What is a major concern that could potentially block the Bayer-Monsanto deal?

• Market competition

• Antitrust regulations

• Shareholder approval

• Environmental impact

What business is Bayer considering selling to address antitrust concerns?

• Dermatology

• Biotechnology

• Agriculture

• Pharmaceuticals

Why might Bayer need to sell parts of its seeds and pesticides portfolio?

• To increase market share

• To focus on core businesses

• To comply with regulatory requirements

• To reduce debt

What is the total amount Bayer is looking to spend on the Monsanto deal?

• $65 billion

• $56 billion

• $50 billion

• $60 billion